Key facts
- Cipher Surgical’s last known valuation is $26.0M (Sep 2021).
- It has raised $37.3M; the latest was Later Stage VC ($10.0M) in Apr 2025.
- Notable investors include Innovate UK, Keiretsu Forum, Future Planet Capital, ACF Investors, London Business Angels — 17 tracked in total.
- Cipher Surgical has filed 2 Form Ds with the SEC since 2015, most recently Apr 2018 ( sold).
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Cipher Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Cipher Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cipher Surgical
Provider of surgical medical devices intended to help surgeons maintain a clear distal window of the laparoscope. The company's device uses in-situ on demand carbon dioxide and saline lens wash, improving the efficiency and safety of minimally invasive surgery through the development and commercialization of products that maintain surgical vision, enabling surgeons to make abdominal keyhole surgery quick and safe.
- Sector
- Healthcare
- HQ
- Coventry, United Kingdom
- Founded
- 2010
- Employees
- 12
- Website
- ciphersurgical.com/
- Ownership
- Privately Held (backing)
Cipher Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cipher Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cipher Surgical in its N-PORT filings yet. We sweep new filings monthly.